MYOMO, INC. (MYO) — SEC Financial Statements & Analysis

MYOMO, INC. (MYO) is a orthopedic, prosthetic & surgical appliances & supplies company, incorporated in DE. MYOMO, INC. trades on NYSE as: MYO. MYOMO, INC. (MYO)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-05. Based on that filing, MYOMO, INC. carries a market cap of $44.41M, a P/E ratio of -3.06x, a P/B ratio of 7.62x, a P/S ratio of 1.03x, an enterprise value of $44.72M, and an EV/EBITDA multiple of -4.25x. On profitability, it posts a gross margin of 68.35%, an operating margin of -27.05%, a net margin of -33.53%, a Return on Equity (ROE) of -123.76%, a Return on Assets (ROA) of -39.20%, and a Return on Invested Capital (ROIC) of -155.72%. Per share, it reports EPS of $-0.34, diluted EPS of $-0.34, free cash flow per share of $-0.25, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 6.14% year-over-year, net income growth of 55.60% year-over-year, and EPS growth of 51.54% year-over-year. On the balance sheet, it maintains a current ratio of 2.31x, a quick ratio of 1.73x, working capital of $13.92M, a debt-to-equity ratio of 5.06x, a debt ratio of 0.84, an interest coverage ratio of -6.54x, free cash flow of $-10.80M (TTM), and net debt of $313.04K. Figures sourced from SEC EDGAR.

Market Cap

$44.41M

P/E TTM

-3.06x

EPS TTM

$-0.34

P/B TTM

7.62x

ROE TTM

-123.76%

ROA TTM

-39.20%

Debt To Equity

5.06x

Free Cash Flow TTM

$-10.80M

Net Revenue TTM Growth 1Y

6.14%

Data as of 2026-06-30 · Source: SEC EDGAR